• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY WALLFLEX¿ ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY WALLFLEX¿ ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00516710
Medical Device Problem Code Positioning Problem (3009)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 09/15/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Patient's exact age is unknown; however it was reported that the patient was over the age of 18.(b)(4).The device has been received for analysis; however the evaluation has not been completed.Therefore, the cause of the reported malfunction has not been determined.Upon completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event or Problem Description
It was reported to boston scientific corporation on (b)(6) 2018 that a wallflex esophageal fully covered stent was to be used to treat a malignant stenosis in the cardia of the esophagus during a stent placement procedure performed on (b)(6) 2018.Reportedly, the patient¿s anatomy was not tortuous and was not dilated prior to stent placement.According to the complainant, during the procedure, the stent was able to be deployed.However, when the stent was viewed endoscopically to check for placement, the stent was noted to have moved towards the stomach due to peristalsis.The stent was removed with forceps and the procedure was completed with a different device.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Additional Manufacturer Narrative
A deployed wallflex esophageal fully covered stent and delivery system were received for analysis.Visual examination of the returned device identified no issue with the stent and delivery system.The stent was measured to be within specifications.Taking all available information into consideration, the investigation concluded that the reported failure was likely due to anatomical or procedural factors encountered during the procedure which limited the performance of the device.Therefore, the most probable root cause for this complaint is operational context.A labeling review was performed, and from the information available, this device was used per the directions for use (dfu) / product label.A review of the device history record (dhr) confirmed that the device met all material, assembly and product specifications at the time of release to distribution.A search of the complaint database revealed that no other similar complaints exist for the specified batch.
 
Event or Problem Description
It was reported to boston scientific corporation on (b)(6) 2018 that a wallflex esophageal fully covered stent was to be used to treat a malignant stenosis in the cardia of the esophagus during a stent placement procedure performed on (b)(6) 2018.Reportedly, the patient¿s anatomy was not tortuous and was not dilated prior to stent placement.According to the complainant, during the procedure, the stent was able to be deployed.However, when the stent was viewed endoscopically to check for placement, the stent was noted to have moved towards the stomach due to peristalsis.The stent was removed with forceps and the procedure was completed with a different device.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be stable.Corrected information received on april 09, 2018.According to the complainant, the correct procedure date is (b)(6) 2017.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX¿ ESOPHAGEAL
Common Device Name
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key7306124
Report Number3005099803-2018-00588
Device Sequence Number957471
Product Code ESW
UDI-Device Identifier08714729778073
UDI-Public08714729778073
Combination Product (Y/N)N
Initial Reporter CountryCN
PMA/510(K) Number
K091510
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/08/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/26/2017
Device Model NumberM00516710
Device Catalogue Number1671
Device Lot Number0019192925
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/24/2018
Initial Date Received by Manufacturer 02/08/2018
Supplement Date Received by Manufacturer04/09/2018
Initial Report FDA Received Date03/01/2018
Supplement Report FDA Received Date05/04/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-